Aveanna Healthcare (AVAH) Stock: Buy, Sell, or Hold?
AVAH - Aveanna Healthcare Holdings Inc. Common Stock
$13.38
0.06 (0.45%)
â˛
5d:
+8.43%
30d:
+8.08%
90d:
+38.37%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
11d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 19, 2026 at $12.46 · last confirmed Oct 19, 2026
Strength: 4.9/10
Get Alerted When AVAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AVAH is fairly priced but lacks strong directional signals. At 6.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AVAH is fairly priced but lacks strong directional signals. At 6.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.68
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$9.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVAH is currently trading at $13.38, which is considered slightly high relative to its 30-day fair value range of $12.19 to $13.53. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.7) compared to its historical average (12.3). At these levels, the market is pricing in 6.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is approaching resistance at $13.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AVAH scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.85 (+11.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is approaching resistance at $13.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AVAH scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.85 (+11.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$12.19 -
$13.53
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.5%
Protect Your Profits
Holding AVAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($14.85)
- NEUTRAL: Trading at premium valuation - market expects 6.1% growth which is achievable
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$12.19 -
$13.53
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$12.03
Resistance Level
$13.42
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.74
Wall Street Target
$14.85
(+11.0%)
Revenue Growth (YoY)
13.7%
Earnings Growth (YoY)
38.5%
Profit Margin
10.6%
Valuation Premium vs History
+6.1% premium
PE vs Historical
14.7 vs 12.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.1%
(market-implied from PE analysis)
1-Year Target
$14.20
(+6%)
2-Year Target
$15.06
(+13%)
3-Year Target
$15.98
(+19%)
3-Yr Target (if PE normalizes)
(PE: 15â12)
PE COMPRESSION
$13.34
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 10.1%)
$24.08
(+80%)
Base:
(SPY PE: 14.7, Growth: 10.1%)
$17.87
(+34%)
Bear:
(PE: 12.3, Growth: 10.1%)
$14.91
(+12%)
đ
Valuation based on Current Earnings
Trailing PE: 10.57 | Current EPS (TTM): $1.26
Bull Case
$10.56
(-21%)
Analyst growth -28.0%, PE expands to 11.6
Base Case
$9.60
(-28%)
Market implied -28.0%, PE stable at 10.6
Bear Case
$9.06
(-32%)
Severe decline -20.0%, PE contracts to 9.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 9:53 PM ET
Data refreshes hourly during market hours. Next update: 10:53 PM
Data refreshes hourly during market hours. Next update: 10:53 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$286 | 51 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 49 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 50 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
14 analysts |
$134 | 54 HOLD |
Advanced AVAH Option Strategies
Professional options setups generated by AI based on today's AVAH price and gamma walls.
